While this year’s health-care allocations are aggressive in certain key sectors, it has failed expectations that Budget 2026 would be a milestone for increased health-care spending as a percentage of GDP. The total allocation this year is over ₹1.05 lakh crore, marking an increase of about 10% over the previous year’s revised estimates. However, experts have pointed out that the 2026 health budget is approximately 1.9% of the total government expenditure, and about 0.26% of GDP. Finance Minister Nirmala Sitharaman fronted the Biopharma SHAKTI scheme, among the projects with the single highest budgetary allocations this year. This ₹10,000 crore government initiative will transform India into a manufacturing hub for biologics and biosimilars over the next five years, she said. A pan-country clinical state-of-the-art trial infrastructure will also be created, through a network of 1,000 accredited clinical trial sites. No doubt, this will take care of an angle that has long been languishing in India — research and development. Additionally, the government will set up three new National Institutes of Pharmaceutical Education and Research (NIPER) and modernise seven existing units, besides establishing a second NIMHANS campus in north India and two upgraded national mental health institutes. The government has set itself a target of training one lakh allied health professionals over the next five years, while another 1.5 lakh care workers will also be trained to take care of the health needs of the elderly; this is appreciable at a time when India is well on its way towards becoming a grey nation, with fertility levels falling. In the area of making care affordable, the government has exempted 17 cancer medicines and several treatments for rare diseases from customs and import duties, while also reducing the tax collected at source on medical and educational remittances from 5% to 2%. For patients suffering from these conditions, and their families, this will no doubt lead to better affordability for treatments.
Primarily under fire was the Union government’s stodgy refusal to increase the allocation for health care to reach 2.5% of GDP by 2025, as committed in the National Health Policy of 2017. Public health activists have lambasted the drop in funding for the National Health Mission, despite the fact that funds have been consistently well utilised here. While fiscal devolution has enabled States to invest more heavily in the health sector, there are concerns, however, that the Centre steadily reducing its share will result in patchy outcomes, not even improvements, in the health-care sector of the country.
Published – February 06, 2026 12:10 am IST
